{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T16:45:14Z","timestamp":1792255514766,"version":"4.4.0"},"reference-count":104,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T00:00:00Z","timestamp":1761091200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001665","name":"French National Research Agency","doi-asserted-by":"publisher","award":["ANR-15-CE18-0010-03"],"award-info":[{"award-number":["ANR-15-CE18-0010-03"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007586","name":"Aix-Marseille Universit\u00e9","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007586","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004794","name":"Centre National de la Recherche Scientifique","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004794","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.jconrel.2025.114344","type":"journal-article","created":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T23:24:30Z","timestamp":1760743470000},"page":"114344","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"P2","title":["Novel single-domain antibodies targeting a unique transferrin receptor 1 epitope for cross-species delivery of drugs in the central nervous system"],"prefix":"10.1016","volume":"388","author":[{"given":"Marion","family":"David","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romy","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane","family":"Beuzelin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00e9raldine","family":"Ferracci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Cresci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aude","family":"Faucon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karima","family":"Abouzid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gersande","family":"Godefroy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxime","family":"Masse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasmine","family":"Mechioukhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phane D.","family":"Girard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid","family":"Julien-Gau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cl\u00e9a","family":"Boursery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Fraisier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karine","family":"Varini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgane","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Jacquot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascaline","family":"L\u00e9corch\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bastien","family":"Serrano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9a","family":"Romette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gauthier Dangla","family":"P\u00e9lissier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magali","family":"Godard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Saillant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiphanie","family":"Pruvost","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raphael","family":"Sierocki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Chames","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitte","family":"Kerfelec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamal","family":"Temsamani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Khrestchatisky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2025.114344_bb0005","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1602\/neurorx.2.1.3","article-title":"The blood-brain barrier: bottleneck in brain drug development","volume":"2","author":"Pardridge","year":"2005","journal-title":"NeuroRx"},{"key":"10.1016\/j.jconrel.2025.114344_bb0010","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.2174\/1381612043384844","article-title":"ABC transporters and the blood-brain barrier","volume":"10","author":"Begley","year":"2004","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.jconrel.2025.114344_bb0015","doi-asserted-by":"crossref","first-page":"4942","DOI":"10.1021\/jm990017w","article-title":"Murcko, designing libraries with CNS activity","volume":"42","author":"Ajay","year":"1999","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jconrel.2025.114344_bb0020","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1021\/cc9800071","article-title":"A knowledge-based approach in designing combinatorial or medicinal chemistry libraries for drug discovery. 1. A qualitative and quantitative characterization of known drug databases","volume":"1","author":"Ghose","year":"1999","journal-title":"J. Comb. Chem."},{"key":"10.1016\/j.jconrel.2025.114344_bb0025","series-title":"Ageing and Health","author":"WHO","year":"2022"},{"key":"10.1016\/j.jconrel.2025.114344_bb0030","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2019.00373","article-title":"Blood-brain barrier and delivery of protein and gene therapeutics to brain","volume":"11","author":"Pardridge","year":"2020","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.jconrel.2025.114344_bb0035","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1124\/mi.3.2.90","article-title":"Blood-brain barrier drug targeting: the future of brain drug development","volume":"3","author":"Pardridge","year":"2003","journal-title":"Mol. Interv."},{"key":"10.1016\/j.jconrel.2025.114344_bb0040","doi-asserted-by":"crossref","first-page":"489","DOI":"10.4155\/tde.10.44","article-title":"Peptide-based vectors for blood-brain barrier targeting and delivery of drugs to the central nervous system","volume":"1","author":"Vlieghe","year":"2010","journal-title":"Ther. Deliv."},{"key":"10.1016\/j.jconrel.2025.114344_bb0045","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1002\/med.21252","article-title":"Medicinal chemistry based approaches and nanotechnology-based systems to improve CNS drug targeting and delivery","volume":"33","author":"Vlieghe","year":"2013","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.jconrel.2025.114344_bb0050","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1016\/j.msec.2017.02.056","article-title":"Non-invasive approaches for drug delivery to the brain based on the receptor mediated transport","volume":"76","author":"Fang","year":"2017","journal-title":"Mater. Sci. Eng. C"},{"key":"10.1016\/j.jconrel.2025.114344_bb0055","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1007\/s11095-007-9379-0","article-title":"Blood-brain barrier transport of therapeutics via receptor-mediation","volume":"24","author":"Jones","year":"2007","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2025.114344_bb0060","first-page":"281","article-title":"Blood-brain barrier and new approaches to brain drug delivery","volume":"156","author":"Pardridge","year":"1992","journal-title":"West. J. Med."},{"key":"10.1016\/j.jconrel.2025.114344_bb0065","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.conb.2018.12.014","article-title":"Transcytosis at the blood-brain barrier","volume":"57","author":"Ayloo","year":"2019","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.jconrel.2025.114344_bb0070","doi-asserted-by":"crossref","first-page":"3256","DOI":"10.1016\/j.celrep.2017.11.055","article-title":"Sorting tubules regulate blood-brain barrier transcytosis","volume":"21","author":"Villase\u00f1or","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.jconrel.2025.114344_bb0075","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1152\/physrev.00001.2003","article-title":"Transcytosis: crossing cellular barriers","volume":"83","author":"Tuma","year":"2003","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.jconrel.2025.114344_bb0080","doi-asserted-by":"crossref","DOI":"10.3389\/fddev.2024.1360302","article-title":"Receptor-mediated transcytosis for brain delivery of therapeutics: receptor classes and criteria","volume":"4","author":"Haqqani","year":"2024","journal-title":"Front. Drug Deliv."},{"key":"10.1016\/j.jconrel.2025.114344_bb0085","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0092-8674(04)00130-8","article-title":"Structure of the human transferrin receptor-transferrin complex","volume":"116","author":"Cheng","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.jconrel.2025.114344_bb0090","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1038\/s41467-019-09098-w","article-title":"Cryo-EM structure of the human ferritin\u2013transferrin receptor 1 complex","volume":"10","author":"Montemiglio","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2025.114344_bb0095","doi-asserted-by":"crossref","first-page":"3505","DOI":"10.1073\/pnas.0913192107","article-title":"Binding and uptake of H-ferritin are mediated by human transferrin receptor-1","volume":"107","author":"Li","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2025.114344_bb0100","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/312162a0","article-title":"Transferrin receptor on endothelium of brain capillaries","volume":"312","author":"Jefferies","year":"1984","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2025.114344_bb0105","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/0026-0495(87)90099-0","article-title":"Human blood-brain barrier transferrin receptor","volume":"36","author":"Pardridge","year":"1987","journal-title":"Metab. Clin. Exp."},{"key":"10.1016\/j.jconrel.2025.114344_bb0110","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/jnr.490180206","article-title":"Receptor-mediated transcytosis of transferrin across the blood-brain barrier","volume":"18","author":"Fishman","year":"1987","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.jconrel.2025.114344_bb0115","doi-asserted-by":"crossref","first-page":"8254","DOI":"10.1016\/S0021-9258(18)42435-0","article-title":"Transferrin receptor gene is hyperexpressed and transcriptionally regulated in differentiating erythroid cells","volume":"267","author":"Chan","year":"1992","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2025.114344_bb0120","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.ijpharm.2009.04.035","article-title":"Characterization of endocytosis of transferrin-coated PLGA nanoparticles by the blood-brain barrier","volume":"379","author":"Chang","year":"2009","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2025.114344_bb0125","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14102237","article-title":"Blood-brain barrier transport of transferrin receptor-targeted nanoparticles","volume":"14","author":"Thomsen","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2025.114344_bb0130","doi-asserted-by":"crossref","first-page":"8662","DOI":"10.1073\/pnas.1307152110","article-title":"Transcytosis and brain uptake of transferrin-containing nanoparticles by tuning avidity to transferrin receptor","volume":"110","author":"Wiley","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2025.114344_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2023.106934","article-title":"Ferritin nanoconjugates guide trastuzumab brain delivery to promote an antitumor response in murine HER2 + breast cancer brain metastasis","volume":"196","author":"Sevieri","year":"2023","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.jconrel.2025.114344_bb0140","doi-asserted-by":"crossref","first-page":"535","DOI":"10.3390\/ph14060535","article-title":"Mathematical models of blood-brain barrier transport of monoclonal antibodies targeting the transferrin receptor and the insulin receptor","volume":"14","author":"Pardridge","year":"2021","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.jconrel.2025.114344_bb0145","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15030739","article-title":"CDR3 variants of the TXB2 shuttle with increased TfR1 association rate and enhanced brain penetration","volume":"15","author":"Stocki","year":"2023","journal-title":"Pharmaceutics"},{"issue":"2","key":"10.1016\/j.jconrel.2025.114344_bb0150","article-title":"Blood-brain barrier transport using a high affinity, brain-selective VNAR antibody targeting transferrin receptor 1","volume":"35","author":"Stocki","year":"2021","journal-title":"FASEB journal\u202f: official publication of the Federation of American Societies for, Exp. Biol."},{"key":"10.1016\/j.jconrel.2025.114344_bb0155","doi-asserted-by":"crossref","first-page":"261ra154","DOI":"10.1126\/scitranslmed.3009835","article-title":"Therapeutic bispecific antibodies cross the blood-brain barrier in nonhuman primates","volume":"6","author":"Yu","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jconrel.2025.114344_bb0160","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1080\/19420862.2018.1465159","article-title":"Brain uptake of multivalent and multi-specific DVD-Ig proteins after systemic administration","volume":"10","author":"Karaoglu Hanzatian","year":"2018","journal-title":"mAbs"},{"key":"10.1016\/j.jconrel.2025.114344_bb0165","series-title":"Fluids and Barriers of the CNS","first-page":"62","article-title":"Identification and in vivo characterization of a brain-penetrating nanobody","volume":"17","author":"Wouters","year":"2020"},{"key":"10.1016\/j.jconrel.2025.114344_bb0170","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1046\/j.1471-4159.2001.00541.x","article-title":"Restricted transport of anti-transferrin receptor antibody (OX26) through the blood-brain barrier in the rat","volume":"79","author":"Moos","year":"2001","journal-title":"J. Neurochem."},{"key":"10.1016\/j.jconrel.2025.114344_bb0175","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S0022-3565(25)20567-5","article-title":"Selective transport of an anti-transferrin receptor antibody through the blood-brain barrier in vivo","volume":"259","author":"Pardridge","year":"1991","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"6","key":"10.1016\/j.jconrel.2025.114344_bb0180","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1111\/jnc.14482","article-title":"Intracellular sorting and transcytosis of the rat transferrin receptor antibody OX26 across the blood-brain barrier in vitro is dependent on its binding affinity","volume":"146","author":"Haqqani","year":"2018","journal-title":"J. Neurochem."},{"key":"10.1016\/j.jconrel.2025.114344_bb0185","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1517\/17425247.2014.952627","article-title":"Blood-brain barrier drug delivery of IgG fusion proteins with a transferrin receptor monoclonal antibody","volume":"12","author":"Pardridge","year":"2015","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.jconrel.2025.114344_bb0190","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1002\/bit.22135","article-title":"Engineering and expression of a chimeric transferrin receptor monoclonal antibody for blood-brain barrier delivery in the mouse","volume":"102","author":"Boado","year":"2009","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.jconrel.2025.114344_bb0195","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.ejps.2013.05.027","article-title":"Study of the transcytosis of an anti-transferrin receptor antibody with a fab\u2019 cargo across the blood-brain barrier in mice","volume":"49","author":"Manich","year":"2013","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2025.114344_bb0200","doi-asserted-by":"crossref","first-page":"308","DOI":"10.7150\/thno.17155","article-title":"Bivalent brain shuttle increases antibody uptake by monovalent binding to the transferrin receptor","volume":"7","author":"Hultqvist","year":"2017","journal-title":"Theranostics"},{"key":"10.1016\/j.jconrel.2025.114344_bb0205","doi-asserted-by":"crossref","first-page":"17254","DOI":"10.1038\/s41598-017-17358-2","article-title":"Pharmacokinetics, biodistribution and brain retention of a bispecific antibody-based PET radioligand for imaging of amyloid-beta","volume":"7","author":"Sehlin","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2025.114344_bb0210","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.medj.2022.09.007","article-title":"Enhanced delivery of antibodies across the blood-brain barrier via TEMs with inherent receptor-mediated phagocytosis","volume":"3","author":"Edavettal","year":"2022","journal-title":"Med"},{"key":"10.1016\/j.jconrel.2025.114344_bb0215","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15061748","article-title":"Novel human\/non-human primate cross-reactive anti-transferrin receptor Nanobodies for brain delivery of biologics","volume":"15","author":"Ru\u00e9","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2025.114344_bb0220","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aay1359","article-title":"Brain delivery of therapeutic proteins using an fc fragment blood-brain barrier transport vehicle in mice and monkeys","volume":"12","author":"Kariolis","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jconrel.2025.114344_bb0225","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1016\/j.ymthe.2018.02.032","article-title":"A blood-brain-barrier-penetrating anti-human transferrin receptor antibody fusion protein for neuronopathic mucopolysaccharidosis II","volume":"26","author":"Sonoda","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2025.114344_bb0230","first-page":"276","article-title":"Bispecific antibodies for cancer therapy","volume":"12","author":"Chames","year":"2009","journal-title":"Curr. Opin. Drug Discov. Devel."},{"key":"10.1016\/j.jconrel.2025.114344_bb0235","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/978-1-61779-968-6_2","article-title":"Introduction to heavy chain antibodies and derived Nanobodies","volume":"911","author":"Vincke","year":"2012","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.jconrel.2025.114344_bb0240","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0006-8993(95)00836-F","article-title":"Permeability of the blood-brain barrier to the neurotensin8\u201313 analog NT1","volume":"695","author":"Banks","year":"1995","journal-title":"Brain Res."},{"key":"10.1016\/j.jconrel.2025.114344_bb0245","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1074\/mcp.O112.025486","article-title":"Masked selection: a straightforward and flexible approach for the selection of binders against specific epitopes and differentially expressed proteins by phage display","volume":"13","author":"Even-Desrumeaux","year":"2014","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.jconrel.2025.114344_bb0250","doi-asserted-by":"crossref","DOI":"10.1002\/wcms.1298","article-title":"Using PyMOL as a platform for computational drug design","volume":"7","author":"Yuan","year":"2017","journal-title":"WIREs Comput. Mol. Sci."},{"key":"10.1016\/j.jconrel.2025.114344_bb0255","doi-asserted-by":"crossref","first-page":"13089","DOI":"10.1073\/pnas.1105786108","article-title":"How the binding of human transferrin primes the transferrin receptor potentiating iron release at endosomal pH","volume":"108","author":"Eckenroth","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2025.114344_bb0260","doi-asserted-by":"crossref","first-page":"4586","DOI":"10.1073\/pnas.0505379103","article-title":"Molecular basis for the preferential cleft recognition by dromedary heavy-chain antibodies","volume":"103","author":"De Genst","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2025.114344_bb0265","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1146\/annurev-biochem-063011-092449","article-title":"Nanobodies: natural single-domain antibodies","volume":"82","author":"Muyldermans","year":"2013","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.jconrel.2025.114344_bb0270","doi-asserted-by":"crossref","first-page":"3273","DOI":"10.1074\/jbc.M806889200","article-title":"General strategy to humanize a camelid single-domain antibody and identification of a universal humanized nanobody scaffold","volume":"284","author":"Vincke","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2025.114344_bb0275","doi-asserted-by":"crossref","first-page":"D297","DOI":"10.1093\/nar\/gkt1208","article-title":"MMDB and VAST+: tracking structural similarities between macromolecular complexes","volume":"42","author":"Madej","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jconrel.2025.114344_bb0280","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2017708118","article-title":"Improved RAD51 binders through motif shuffling based on the modularity of BRC repeats","volume":"118","author":"Lindenburg","year":"2021","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.jconrel.2025.114344_bb0285","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2022.945808","article-title":"Antibody-antigen binding Interface analysis in the big data era","volume":"9","author":"Reis","year":"2022","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.jconrel.2025.114344_bb0290","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3005338","article-title":"Addressing safety liabilities of TfR bispecific antibodies that cross the blood-brain barrier","volume":"5","author":"Couch","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jconrel.2025.114344_bb0295","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.celrep.2017.12.019","article-title":"Brain shuttle antibody for Alzheimer\u2019s disease with attenuated peripheral effector function due to an inverted binding mode","volume":"22","author":"Weber","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.jconrel.2025.114344_bb0300","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.neuron.2013.10.061","article-title":"Increased brain penetration and potency of a therapeutic antibody using a monovalent molecular shuttle","volume":"81","author":"Niewoehner","year":"2014","journal-title":"Neuron"},{"key":"10.1016\/j.jconrel.2025.114344_bb0305","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1172\/JCI70647","article-title":"Conjugation of a brain-penetrant peptide with neurotensin provides antinociceptive properties","volume":"124","author":"Demeule","year":"2014","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jconrel.2025.114344_bb0310","doi-asserted-by":"crossref","DOI":"10.1016\/j.pneurobio.2019.101665","article-title":"Targeting the transferrin receptor for brain drug delivery","volume":"181","author":"Johnsen","year":"2019","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.jconrel.2025.114344_bb0315","unstructured":"Transferrin Receptor-binding Molecules, Conjugates Thereof and Their Uses to Prevent or Treat Muscular Diseases. Applicants: Vect-Horus; CNRS; Universit\u00e9 d'Aix-Marseille; 2024. Available from: https:\/\/patentscope.wipo.int\/search\/en\/detail.jsf?docId=WO2024261332."},{"key":"10.1016\/j.jconrel.2025.114344_bb0320","unstructured":"Transferrin Receptor-binding Molecules, Conjugates Thereof and their Uses to Prevent or Treat CNS Diseases. Applicants: Vect-Horus; CNRS; Universit\u00e9 d'Aix-Marseille; 2024. Available from: https:\/\/patentscope.wipo.int\/search\/en\/detail.jsf?docId=WO2024261333."},{"key":"10.1016\/j.jconrel.2025.114344_bb0325","unstructured":"Transferrin Receptor-binding Molecules, Conjugates Thereof and Their Uses. Applicants: Vect-Horus; CNRS; Universit\u00e9 d'Aix-Marseille; 2020. Available from: https:\/\/patentscope.wipo.int\/search\/en\/detail.jsf?docId=WO2020144233."},{"key":"10.1016\/j.jconrel.2025.114344_bb0330","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.coi.2016.02.003","article-title":"Distinct antibody species: structural differences creating therapeutic opportunities","volume":"40","author":"Muyldermans","year":"2016","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.jconrel.2025.114344_bb0335","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1093\/jb\/mvt058","article-title":"Affinity maturation of a CDR3-grafted VHH using in silico analysis and surface plasmon resonance","volume":"154","author":"Inoue","year":"2013","journal-title":"J. Biochem."},{"issue":"4","key":"10.1016\/j.jconrel.2025.114344_bb0340","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1021\/acs.molpharmaceut.7b00937","article-title":"Enhanced delivery of galanin conjugates to the brain through bioengineering of the anti-transferrin receptor antibody OX26","volume":"15","author":"Thom","year":"2018","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2025.114344_bb0345","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1124\/dmd.109.031534","article-title":"Monoclonal antibody-glial-derived neurotrophic factor fusion protein penetrates the blood-brain barrier in the mouse","volume":"38","author":"Zhou","year":"2010","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.jconrel.2025.114344_bb0350","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/S0022-3565(24)35388-1","article-title":"Targeting rat anti-mouse transferrin receptor monoclonal antibodies through blood-brain barrier in mouse","volume":"292","author":"Lee","year":"2000","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.jconrel.2025.114344_bb0355","series-title":"Fluids and Barriers of the CNS","first-page":"79","article-title":"VHHs as tools for therapeutic protein delivery to the central nervous system","volume":"19","author":"Wouters","year":"2022"},{"key":"10.1016\/j.jconrel.2025.114344_bb0360","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aay1163","article-title":"Brain delivery and activity of a lysosomal enzyme using a blood-brain barrier transport vehicle in mice","volume":"12","author":"Ullman","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jconrel.2025.114344_bb0365","doi-asserted-by":"crossref","first-page":"2261509","DOI":"10.1080\/19420862.2023.2261509","article-title":"Delivery of the Brainshuttle\u2122 amyloid-beta antibody fusion trontinemab to non-human primate brain and projected efficacious dose regimens in humans","volume":"15","author":"Grimm","year":"2023","journal-title":"mAbs"},{"key":"10.1016\/j.jconrel.2025.114344_bb0370","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.ymthe.2020.09.039","article-title":"A phase 2\/3 trial of Pabinafusp Alfa, IDS fused with anti-human transferrin receptor antibody, targeting neurodegeneration in MPS-II","volume":"29","author":"Okuyama","year":"2021","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2025.114344_bb0375","doi-asserted-by":"crossref","first-page":"2410968","DOI":"10.1080\/19420862.2024.2410968","article-title":"Single domain antibody-scFv conjugate targeting amyloid \u03b2 and TfR penetrates the blood-brain barrier and interacts with amyloid \u03b2","volume":"16","author":"Faresj\u00f6","year":"2024","journal-title":"mAbs"},{"key":"10.1016\/j.jconrel.2025.114344_bb0380","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202001787R","article-title":"Blood-brain barrier transport using a high affinity, brain-selective VNAR antibody targeting transferrin receptor 1","volume":"35","author":"Stocki","year":"2021","journal-title":"FASEB J."},{"key":"10.1016\/j.jconrel.2025.114344_bb0385","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.00273","article-title":"Single-domain antibodies and the promise of modular targeting in Cancer imaging and treatment","volume":"9","author":"Iezzi","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2025.114344_bb0390","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0092-8674(00)81151-4","article-title":"Crystal structure of the hemochromatosis protein HFE and characterization of its interaction with transferrin receptor","volume":"93","author":"Lebr\u00f3n","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.jconrel.2025.114344_bb0395","article-title":"Self-assembled antibody-oligonucleotide conjugates for targeted delivery of complementary antisense oligonucleotides","volume":"64","author":"Zhou","year":"2025","journal-title":"Angew. Chem."},{"key":"10.1016\/j.jconrel.2025.114344_bb0400","doi-asserted-by":"crossref","first-page":"84ra44","DOI":"10.1126\/scitranslmed.3002230","article-title":"Boosting brain uptake of a therapeutic antibody by reducing its affinity for a transcytosis target","volume":"3","author":"Yu","year":"2011","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jconrel.2025.114344_bb0405","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1084\/jem.20131660","article-title":"Transferrin receptor (TfR) trafficking determines brain uptake of TfR antibody affinity variants","volume":"211","author":"Bien-Ly","year":"2014","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jconrel.2025.114344_bb0410","first-page":"58","article-title":"Tetravalent bispecific tandem antibodies improve brain exposure and efficacy in an amyloid transgenic mouse model","volume":"19","author":"Do","year":"2020","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2025.114344_bb0415","doi-asserted-by":"crossref","DOI":"10.3389\/fddev.2023.1227816","article-title":"Receptor-mediated drug delivery of bispecific therapeutic antibodies through the blood-brain barrier","volume":"3","author":"Pardridge","year":"2023","journal-title":"Front. Drug Deliv."},{"key":"10.1016\/j.jconrel.2025.114344_bb0420","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20211057","article-title":"Molecular architecture determines brain delivery of a transferrin receptor-targeted lysosomal enzyme","volume":"219","author":"Arguello","year":"2022","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jconrel.2025.114344_bb0425","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.958543","article-title":"Investigating brain uptake of a non-targeting monoclonal antibody after intravenous and intracerebroventricular administration","volume":"13","author":"Van De Vyver","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jconrel.2025.114344_bb0430","doi-asserted-by":"crossref","first-page":"1874121","DOI":"10.1080\/19420862.2021.1874121","article-title":"Brain pharmacokinetics of anti-transferrin receptor antibody affinity variants in rats determined using microdialysis","volume":"13","author":"Chang","year":"2021","journal-title":"mAbs"},{"key":"10.1016\/j.jconrel.2025.114344_bb0440","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.100527","article-title":"A peptide-neurotensin conjugate that crosses the blood-brain barrier induces pharmacological hypothermia associated with anticonvulsant, neuroprotective, and anti-inflammatory properties following status epilepticus in mice","volume":"13","author":"Ferhat","year":"2025","journal-title":"Elife"},{"key":"10.1016\/j.jconrel.2025.114344_bb0445","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2020.108069","article-title":"Neurotensin induces hypothermia by activating both neuronal neurotensin receptor 1 and astrocytic neurotensin receptor 2 in the median preoptic nucleus","volume":"171","author":"Tabarean","year":"2020","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.jconrel.2025.114344_bb0450","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.1002\/glia.24062","article-title":"Neurotensin receptor 2 is induced in astrocytes and brain endothelial cells in relation to neuroinflammation following pilocarpine-induced seizures in rats","volume":"69","author":"Kyriatzis","year":"2021","journal-title":"Glia"},{"key":"10.1016\/j.jconrel.2025.114344_bb0455","first-page":"3969","volume":"26","author":"Li","year":"2012","journal-title":"Exp. Biol."},{"key":"10.1016\/j.jconrel.2025.114344_bb0460","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2016.09.019","article-title":"Camelid single-domain antibodies: a versatile tool for in vivo imaging of extracellular and intracellular brain targets","volume":"243","author":"Li","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.114344_bb0465","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s00441-006-0162-z","article-title":"Differential uptake of molecules from the circulation and CSF reveals regional and cellular specialisation in CNS detection of homeostatic signals","volume":"325","author":"Cheunsuang","year":"2006","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.jconrel.2025.114344_bb0470","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2022.991779","article-title":"Glial functions in the blood-brain communication at the circumventricular organs","volume":"16","author":"Miyata","year":"2022","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.jconrel.2025.114344_bb0475","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0276107","article-title":"Selection of single domain anti-transferrin receptor antibodies for blood-brain barrier transcytosis using a neurotensin based assay and histological assessment of target engagement in a mouse model of Alzheimer\u2019s related amyloid-beta pathology","volume":"17","author":"Su","year":"2022","journal-title":"PloS One"},{"key":"10.1016\/j.jconrel.2025.114344_bb0480","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s00253-007-1142-2","article-title":"Properties, production, and applications of camelid single-domain antibody fragments","volume":"77","author":"Harmsen","year":"2007","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.jconrel.2025.114344_bb0490","series-title":"Fluids and Barriers of the CNS","first-page":"64","article-title":"Enhanced in vivo blood brain barrier transcytosis of macromolecular cargo using an engineered pH-sensitive mouse transferrin receptor binding nanobody","volume":"20","author":"Esparza","year":"2023"},{"key":"10.1016\/j.jconrel.2025.114344_bb0495","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics12100937","article-title":"Brain delivery of single-domain antibodies: a focus on VHH and VNAR","volume":"12","author":"Pothin","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2025.114344_bb0505","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1016\/j.molimm.2006.08.007","article-title":"Generation of llama single-domain antibodies against methotrexate, a prototypical hapten","volume":"44","author":"Alvarez-Rueda","year":"2007","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.jconrel.2025.114344_bb0510","doi-asserted-by":"crossref","first-page":"3881","DOI":"10.1111\/j.1742-4658.2009.07101.x","article-title":"Llama single-domain antibodies directed against nonconventional epitopes of tumor-associated carcinoembryonic antigen absent from nonspecific cross-reacting antigen","volume":"276","author":"Behar","year":"2009","journal-title":"FEBS J."},{"key":"10.1016\/j.jconrel.2025.114344_bb0515","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1002\/cyto.a.20623","article-title":"MIFlowCyt: the minimum information about a flow cytometry experiment","volume":"73","author":"Lee","year":"2008","journal-title":"Cytometry A"},{"issue":"5","key":"10.1016\/j.jconrel.2025.114344_bb0520","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1096\/fj.201600827R","article-title":"Use of LDL receptor-targeting peptide vectors for in vitro and in vivo cargo transport across the blood-brain barrier","volume":"31","author":"Molino","year":"2017","journal-title":"FASEB journal\u202f: official publication of the Federation of American Societies for, Exp. Biol."},{"key":"10.1016\/j.jconrel.2025.114344_bb0525","article-title":"Setting-up an in vitro model of rat blood-brain barrier (BBB): a focus on BBB impermeability and receptor-mediated transport","volume":"JoVE","author":"Molino","year":"2014","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.jconrel.2025.114344_bb0530","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/s41586-024-07487-w","article-title":"Accurate structure prediction of biomolecular interactions with AlphaFold 3","volume":"630","author":"Abramson","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2025.114344_bb0535","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.2144\/00286ir01","article-title":"The sequence manipulation suite: JavaScript programs for analyzing and formatting protein and DNA sequences","volume":"28","author":"Stothard","year":"2000","journal-title":"Biotechniques"}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365925009587?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365925009587?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,7]],"date-time":"2026-06-07T08:55:44Z","timestamp":1780822544000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365925009587"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":104,"alternative-id":["S0168365925009587"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.114344","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel single-domain antibodies targeting a unique transferrin receptor 1 epitope for cross-species delivery of drugs in the central nervous system","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.114344","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"114344"}}